Janssen Global Commercial Strategy Organization, a group within Janssen Global Services and a member of Johnson & Johnson's family of companies, is recruiting for a Global Compound Market Access Leader.

At the Janssen Pharmaceutical Companies of Johnson & Johnson, what matters most is helping people live full and healthy lives. We focus on treating, curing and preventing some of the most devastating and complex diseases of our time. And we pursue the most promising science, wherever it might be found.

Janssen Global Services, LLC encompasses groups that provide leadership across critical business areas for Janssen including, Global Commercial Strategy Organization; Global Pharmaceuticals Communication and Public Affairs; U.S. Pharmaceuticals Procurement Group; and Pharmaceuticals Group Business Development.

The Global Compound Market Access Leader (CMAL), reporting to the Sr CMAL, Access Strategy, Early Products and NBD has the key leadership role of developing and driving the Market Access strategy. The CMAL provides strategic market access leadership at the brand level, expertly representing market access within Compound Development Team and other global strategy teams, building strong relationships and effective collaboration within the matrix. In doing so, the CMAL will shape key strategic decisions through input/contributions to Clinical Development and Integrated Evidence Generation Plans to ensure that strategic plans fully meet the needs of market access in key countries. The CMAL must understand the needs of markets and develop appropriate solutions.

Market Access Strategy:

* Maximizing portfolio value the Early products and NBD team is tasked with:

o Supporting assets and indications ahead of full investment in dedicated product teams, including assets prior to transition to full development, or additional indications outside current disease area strategy team remits

o Evaluation and strategic input into New Business Development opportunities to support maximize deal value and support decision making

* Direct the work of cross functional teams which includes the core functions within Global Market Access (i.e., Health Economics, Patient Reported Outcomes [PRO], Access Policy, Pricing, Real-World Evidence & Analytics) to deliver the global market access strategy for the brand/asset.

* Design, develop and implements an integrated approach to all aspects of the payer value proposition from early development through to appointment of a dedicated product team for a complex portfolio of compounds and indications.

* Responsible for the early strategic planning and implementation of the payer value generation and access strategies.

* Serve as a resource on access strategies and is thought partner of the leaders of global clinical and commercial product teams, as well as the disease area strategy groups.

* Responsible for integrating pricing, payer research, health economic and epidemiology information to develop the optimal value strategy.

* Develop an integrated access strategy that reflects macro (health care reform, quality metrics, technology assessment) and disease specific (clinical profile, market segmentation, disease staging and clinical pathway) factors as well as the complexity of a companion diagnostic.

* Be responsible for ensuring that clinical development programs fully capture the value of innovative products to payers, physicians and patients. This includes strategic advice to teams on patient populations, trial design, and selection of relevant endpoints.

* Drive the design and management of health outcomes studies including: systematic literature reviews, Real World Evidence studies, and user-friendly cost effectiveness and budget impact models, where required to support decision making or ensure launch readiness

* Be responsible for educating the commercial and R&D teams on key access trends and opportunities to shape their evolution.

* Work with the Clinical Development Team (CDT) advising on market access data needs related to the clinical development plan; represent the access needs of the regions as a subject matter expert and advocate for the data necessary for positive reimbursement across the global markets.

* Take budgetary responsibility for defining and managing the market access discretionary budgets, ensuring that spending is managed effectively throughout the year and to plan.

* Keep up to date with scientific developments, and environmental changes in pricing and reimbursement landscape to build the strongest possible value proposition.

* Understand the patient perspective of the disease and recommend strategies that can support the patient voice in key payer negotiations.

Ensure strategic alignment across Regions and Countries:

* Lead an engaged and collaborative Extended Market Access team, ensuring great communication and collaboration, sharing of best practice and co-creation.

* Map the reimbursement pathways and funding mechanisms by key

* To enable timely reimbursement and patient access, proactively support engagements with key external decision makers to reach a consensus on acceptable evidentiary requirements.

* Partner and co-lead with the regions and country teams the preparation and deliverables for early scientific advice engagements.

* Work with pricing colleagues to provide expert perspectives and establish pricing policies

* Oversee the evaluation and modelling of innovative pricing and contracting initiatives and support execution.

* Foster collaboration, alignment, and seamless working across R&D and GCSO functions, including the Clinical Development Team (CDT), Commercial, Medical Affairs, and Global Market Access COE to ensure optimal launch readiness for the brand.